Ellex Medical Lasers - Capitalizing on age-related eye diseases
Ellex’s products target diseases associated with growing ageing populations such as glaucoma and age-related macular degeneration (AMD). FY19 revenue was up 3% to A$81.6m, as robust growth in iTrack, SLT lasers and 2RT was offset by declines in laser devices for other indications and in diagnostic equipment. iTrack, SLT lasers and 2RT appear well-positioned to continue their growth trajectory in FY20 and there may be some recovery in Ellex’s remaining product lines.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.